Bayer Awards $2 Million in Grants to Advance Hemophilia Research and Patient Care

Bayer has awarded grants totaling more than $2 millionto 16 recipients across eight countries as part of its prestigious Bayer Hemophilia Awards Program (BHAP). Four U.S. clinicians and researchers from the Children’s Hospital of Philadelphiaand Uniformed Services University of the Health Sciencesin Marylandare among the winners. Grant recipients were announced last night during a reception at the International Society on Thrombosis and Hemostasis (ISTH) 2017 Congress, Berlin, Germany.

Currently in its 15 year, BHAP is the largest program of its kind that recognizes and supports innovative research and educational initiatives to benefit the hemophilia community and exemplifies Bayer’s mission of ‘Science for a Better Life.’

Read more